Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Reply to: Clinical impact of high platelet count and high hematocrit, by Marc Sorigue.

Warny M, Helby J, Birgens HS, Bojesen SE, Nordestgaard BG.

J Thromb Haemost. 2020 Feb;18(2):522-523. doi: 10.1111/jth.14711. No abstract available.

PMID:
31999057
2.

Incidental lymphopenia and mortality: a prospective cohort study.

Warny M, Helby J, Nordestgaard BG, Birgens H, Bojesen SE.

CMAJ. 2020 Jan 13;192(2):E25-E33. doi: 10.1503/cmaj.191024.

PMID:
31932337
3.

Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.

Warny M, Helby J, Birgens HS, Bojesen SE, Nordestgaard BG.

J Thromb Haemost. 2019 Nov;17(11):1898-1911. doi: 10.1111/jth.14574. Epub 2019 Aug 20.

PMID:
31309714
4.

Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high-risk myelodysplastic syndrome.

Warny M, Helby J, Sengeløv H, Nordestgaard BG, Birgens H, Bojesen SE.

Eur J Haematol. 2019 Mar;102(3):218-226. doi: 10.1111/ejh.13196. Epub 2019 Jan 22.

PMID:
30427547
5.

Lymphopenia and risk of infection and infection-related death in 98,344 individuals from a prospective Danish population-based study.

Warny M, Helby J, Nordestgaard BG, Birgens H, Bojesen SE.

PLoS Med. 2018 Nov 1;15(11):e1002685. doi: 10.1371/journal.pmed.1002685. eCollection 2018 Nov.

6.

Severe G6PD Deficiency Due to a New Missense Mutation in an Infant of Northern European Descent.

Warny M, Lausen B, Birgens H, Knabe N, Petersen J.

J Pediatr Hematol Oncol. 2015 Nov;37(8):e497-9. doi: 10.1097/MPH.0000000000000435.

PMID:
26479991
7.

Prevalence of glucose-6-phosphate dehydrogenase deficiency and diagnostic challenges in 1500 immigrants in Denmark examined for haemoglobinopathies.

Warny M, Klausen TW, Petersen J, Birgens H.

Scand J Clin Lab Invest. 2015 Sep;75(5):390-7. doi: 10.3109/00365513.2015.1031692. Epub 2015 Apr 30.

PMID:
25925739
8.

Phase I dose finding studies of an adjuvanted Clostridium difficile toxoid vaccine.

Greenberg RN, Marbury TC, Foglia G, Warny M.

Vaccine. 2012 Mar 16;30(13):2245-9. doi: 10.1016/j.vaccine.2012.01.065. Epub 2012 Feb 2.

PMID:
22306375
9.

Toxinotype V Clostridium difficile in humans and food animals.

Jhung MA, Thompson AD, Killgore GE, Zukowski WE, Songer G, Warny M, Johnson S, Gerding DN, McDonald LC, Limbago BM.

Emerg Infect Dis. 2008 Jul;14(7):1039-45. doi: 10.3201/eid1407.071641.

10.

Physical characterization of clostridium difficile toxins and toxoids: effect of the formaldehyde crosslinking on thermal stability.

Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR.

J Pharm Sci. 2008 Sep;97(9):3735-52. doi: 10.1002/jps.21261.

PMID:
18257030
11.

Preformulation studies of Clostridium difficile toxoids A and B.

Salnikova MS, Joshi SB, Rytting JH, Warny M, Middaugh CR.

J Pharm Sci. 2008 Oct;97(10):4194-207. doi: 10.1002/jps.21300.

PMID:
18228584
12.

Extracellular nucleotides mediate LPS-induced neutrophil migration in vitro and in vivo.

Kukulski F, Ben Yebdri F, Lefebvre J, Warny M, Tessier PA, Sévigny J.

J Leukoc Biol. 2007 May;81(5):1269-75. Epub 2007 Feb 22.

13.

Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe.

Warny M, Pepin J, Fang A, Killgore G, Thompson A, Brazier J, Frost E, McDonald LC.

Lancet. 2005 Sep 24-30;366(9491):1079-84.

PMID:
16182895
14.

Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis.

Berberat PO, A-Rahim YI, Yamashita K, Warny MM, Csizmadia E, Robson SC, Bach FH.

Inflamm Bowel Dis. 2005 Apr;11(4):350-9.

PMID:
15803024
15.

Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea.

Sougioultzis S, Kyne L, Drudy D, Keates S, Maroo S, Pothoulakis C, Giannasca PJ, Lee CK, Warny M, Monath TP, Kelly CP.

Gastroenterology. 2005 Mar;128(3):764-70.

PMID:
15765411
16.

Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaF508 cystic fibrosis transmembrane conductance regulator gene mutation is altered.

Zaman MM, Gelrud A, Junaidi O, Regan MM, Warny M, Shea JC, Kelly C, O'Sullivan BP, Freedman SD.

Clin Diagn Lab Immunol. 2004 Sep;11(5):819-24.

17.

Active and passive immunization against Clostridium difficile diarrhea and colitis.

Giannasca PJ, Warny M.

Vaccine. 2004 Feb 17;22(7):848-56. Review.

PMID:
15040937
18.

Virulent Toxoplasma gondii strain RH promotes T-cell-independent overproduction of proinflammatory cytokines IL12 and gamma-interferon.

Nguyen TD, Bigaignon G, Markine-Goriaynoff D, Heremans H, Nguyen TN, Warnier G, Delmee M, Warny M, Wolf SF, Uyttenhove C, Van Snick J, Coutelier JP.

J Med Microbiol. 2003 Oct;52(Pt 10):869-76.

PMID:
12972580
19.

Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A.

Aboudola S, Kotloff KL, Kyne L, Warny M, Kelly EC, Sougioultzis S, Giannasca PJ, Monath TP, Kelly CP.

Infect Immun. 2003 Mar;71(3):1608-10.

20.

P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide.

Warny M, Aboudola S, Robson SC, Sévigny J, Communi D, Soltoff SP, Kelly CP.

J Biol Chem. 2001 Jul 13;276(28):26051-6. Epub 2001 May 10.

21.

Saccharomyces boulardii stimulates intestinal immunoglobulin A immune response to Clostridium difficile toxin A in mice.

Qamar A, Aboudola S, Warny M, Michetti P, Pothoulakis C, LaMont JT, Kelly CP.

Infect Immun. 2001 Apr;69(4):2762-5.

22.

Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea.

Kyne L, Warny M, Qamar A, Kelly CP.

Lancet. 2001 Jan 20;357(9251):189-93.

PMID:
11213096
23.

Clostridium difficile toxin A causes early damage to mitochondria in cultured cells.

He D, Hagen SJ, Pothoulakis C, Chen M, Medina ND, Warny M, LaMont JT.

Gastroenterology. 2000 Jul;119(1):139-50.

PMID:
10889163
24.

p38 MAP kinase activation by Clostridium difficile toxin A mediates monocyte necrosis, IL-8 production, and enteritis.

Warny M, Keates AC, Keates S, Castagliuolo I, Zacks JK, Aboudola S, Qamar A, Pothoulakis C, LaMont JT, Kelly CP.

J Clin Invest. 2000 Apr;105(8):1147-56.

25.

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Kyne L, Warny M, Qamar A, Kelly CP.

N Engl J Med. 2000 Feb 10;342(6):390-7.

26.

Differential activation of mitogen-activated protein kinases in AGS gastric epithelial cells by cag+ and cag- Helicobacter pylori.

Keates S, Keates AC, Warny M, Peek RM Jr, Murray PG, Kelly CP.

J Immunol. 1999 Nov 15;163(10):5552-9.

27.

Monocytic cell necrosis is mediated by potassium depletion and caspase-like proteases.

Warny M, Kelly CP.

Am J Physiol. 1999 Mar;276(3):C717-24. doi: 10.1152/ajpcell.1999.276.3.C717.

PMID:
10070000
28.
29.

Intravenous immunoglobulin therapy for severe Clostridium difficile colitis.

Salcedo J, Keates S, Pothoulakis C, Warny M, Castagliuolo I, LaMont JT, Kelly CP.

Gut. 1997 Sep;41(3):366-70.

30.

IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes.

Linevsky JK, Pothoulakis C, Keates S, Warny M, Keates AC, Lamont JT, Kelly CP.

Am J Physiol. 1997 Dec;273(6):G1333-40. doi: 10.1152/ajpgi.1997.273.6.G1333.

PMID:
9435559
31.

Effect of Clostridium difficile toxin A on CD11/CD18 expression in vitro.

Warny M, Chatelain B, Delmée M.

Clin Diagn Lab Immunol. 1996 Sep;3(5):605-7.

32.

The anti-Hu syndrome: a clinical and immunological study of 7 cases.

Pieret F, Sindic CJ, Chalon MP, Warny M, Bolyn S, Dehaene I, Gobiet Y, Goka S, Laloux P, Monteyne P, Peeters A, Pierre P, Gillet S, Van den Bergh PY, Windhausen K, Laterre C.

Acta Neurol Belg. 1996 Jun;96(2):108-16.

PMID:
8711983
33.

Detection of inner ear disease autoantibodies by immunoblotting.

Cao MY, Gersdorff M, Deggouj N, Warny M, Tomasi JP.

Mol Cell Biochem. 1995 May 24;146(2):157-63.

PMID:
7565645
34.

Clostridium difficile colitis: recent therapeutical and immunological considerations.

Delmée M, Warny M.

Acta Gastroenterol Belg. 1995 May-Aug;58(3-4):313-7. Review.

PMID:
7491844
35.
36.

Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Warny M, Vaerman JP, Avesani V, Delmée M.

Infect Immun. 1994 Feb;62(2):384-9.

37.

Anti-neutrophil antibodies in chronic hepatitis and the effect of alpha-interferon therapy.

Warny M, Brenard R, Cornu C, Tomasi JP, Geubel AP.

J Hepatol. 1993 Mar;17(3):294-300.

PMID:
8391039

Supplemental Content

Support Center